Myomo

Myomo PP&E per Employee

The PP&E per Employee of Myomo (MYO) as of Oct 28, 2026 is 88,922.50 USD. In the previous year, PP&E per Employee was 89,146.70 USD — a change of -0.25% (lower).

PP&E per Employee

88,922.50USD

YoY

-0.25%

Last updated:

PP&E per Employee of Myomo is 2025 88,922.50 USD. PP&E per Employee of Myomo was 2024 89,146.70 USD. It decreases by -0.25% lower compared to the previous year.

The Myomo PP&E per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PP&E per Employee
Date
PP&E per Employee
Jan 1, 2018
1,875.13 USD
Jan 1, 2019
1,549.72 USD
Jan 1, 2020
950.23 USD
Jan 1, 2021
9,081.95 USD
Jan 1, 2022
7,030.30 USD
Jan 1, 2023
8,393.50 USD
Jan 1, 2024
89,146.70 USD
Jan 1, 2025
88,922.50 USD
The Myomo PP&E per Employee history
YEARPP&E per EmployeeYoY
88,922.50USD-0.25%
89,146.70USD+962.09%
8,393.50USD+19.39%
7,030.30USD-22.59%
9,081.95USD+855.76%
950.23USD-38.68%
1,549.72USD-17.35%
1,875.13USD+143.05%
771.50USD+257.79%
215.63USD-21.39%
274.30USD+472.53%
47.91USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Myomo Stock analysis

What does Myomo do? Myomo, Inc. generates revenue by selling its MyoPro product line, which consists of myoelectric-controlled upper limb braces designed for patients with neuromuscular disorders. The company directly sells these orthoses to patients and bills their insurance providers for coverage. The MyoPro enables users to control partially paralyzed limbs using their own muscle signals, supporting daily activities like eating and dressing. The target market includes adults and adolescents with conditions such as stroke, spinal cord injury, and brachial plexus injury. The MyoPro product line is marketed as a solution for functional improvement in upper limb paralysis, focusing on home and community use. Myomo’s devices are positioned to help patients regain independence in daily living tasks. Insurance reimbursement is a key revenue stream, with the company handling billing directly to insurers on behalf of patients. The primary customer segments are individuals with neuromuscular conditions requiring orthotic support for upper limb functionality. Myomo is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Myomo stock

PP&E per Employee of Myomo is 88,922.50 USD in 2025.

PP&E per Employee of Myomo changed from 89,146.70 USD to 88,922.50 USD, representing a -0.25% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of PP&E per Employee Myomo since 2006 – with annual values, charts, and detailed analysis.

PP&E per employee measures the physical capital intensity per worker. Higher values indicate more capital-intensive operations.

PP&E per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track PP&E per Employee's Myomo historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Myomo

All Key Metrics — Myomo